Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 32

Trial Status

Completed4

Role Distribution

Principal Investigator3
Other Roles1
PI Rate75%

Activity Timeline

Clinical Trials (4)

NCT02310724Completed
TODAY2 Phase 2 Follow-up
Type 2 Diabetes
PrincipalinvestigatorStart date: 2014-03-01
NCT00694122Phase 3Completed
Comparison of Lantus and Neutral Protamine Hagedorn (NPH) Insulin in the Dawn Phenomenon
Dawn PhenomenonType 1 Diabetes
Principalinvestigator
NCT01794143Phase 3Completed
A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 Diabetes
Comparative Effectiveness of Glycemia-lowering MedicationsType 2 Diabetes
Studychair

Research Network

Collaboration Network

20 collaborators·50 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Rémi Rabasa-Lhoret

Institut de Recherches Cliniques de Montreal

Related
16 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Similarity Score15%

Suman Wason, MD

Lexicon Pharmaceuticals, Inc.

Related
23 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 2Diabetes Mellitus, Type 1

Worked with same sponsors:

Sanofi
Similarity Score15%

Roman Hovorka, PhD

University of Cambridge

Related
13 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2

Worked with same sponsors:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Similarity Score15%

Lisa Porter, MD

Amylin Pharmaceuticals, LLC.

Related
19 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 2Diabetes Mellitus, Type 1
Similarity Score15%

Samuel Klein, MD

Washington University School of Medicine

Related
30 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 2Diabetes Mellitus, Type 1

Worked with same sponsors:

National Heart, Lung, and Blood Institute (NHLBI)National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Similarity Score15%

Bruce Bode, MD

Atlanta Diabetes Associates

Related
8 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Similarity Score15%

Timothy Bailey, MD

AMCR Institute

Related
19 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2

Worked with same sponsors:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Similarity Score15%

Adrian Vella, MD

Mayo Clinic

Related
19 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 2Diabetes Mellitus, Type 1

Worked with same sponsors:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Similarity Score15%

Mustafa H Temel, M.D.

Uskudar State Hospital

Related
23 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Similarity Score15%

Ruth S Weinstock, MD PhD

SUNY Upstate Medical Center

Related
1 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 2

Worked with same sponsors:

National Eye Institute (NEI)National Heart, Lung, and Blood Institute (NHLBI)+1 more
Collaborated on 1 trial
Similarity Score14%

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT02310724PrincipalInvestigator

TODAY2 Phase 2 Follow-up

Type 2 Diabetes
Completed
NCT00607230Phase 1PrincipalInvestigator

Determination of Dosing and Frequency of BCG Administration to Alter T-Lymphocyte Profiles in Type I Diabetics

Type 1 Diabetes Mellitus
Completed
NCT00694122Phase 3PrincipalInvestigator

Comparison of Lantus and Neutral Protamine Hagedorn (NPH) Insulin in the Dawn Phenomenon

Dawn PhenomenonType 1 Diabetes
Completed
NCT01794143Phase 3StudyChair

A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 Diabetes

Comparative Effectiveness of Glycemia-lowering MedicationsType 2 Diabetes
Completed

All 4 trials loaded